TDC
NVLN

Thompson Davis & Co’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Thompson Davis & Co’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,430
Closed -$26K – 1237
2017
Q1 		$26K Buy
+2,430
New +$26K 0.04% 413